EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years

Alp Temiz, Stephan Kemenes, Sara Bayat, Melek Yalcin-Mutlu, Louis Schuster, Katharina Hast-Sribike, Anna-Maria Liphardt, David Simon, Arnd Kleyer, Georg Schett, Filippo Fagni, Koray Tascilar

Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · 2151-2163

DOI: 10.1016/j.ard.2026.07.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Alp Temiz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, G…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Arthritis, Psoriatic, Bone Density, Radius. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic immune-mediated inflammatory diseases associated with progressive bone deterioration. Comparative longitudinal changes in bone density, microarchitecture, and biomechanical properties, and their association with disease activity, remain insufficiently elucidated in seronegative RA (RA-), seropositive RA (RA+), and PsA. METHODS: High-resolution peripheral quantitative computed tomography (HR-pQCT) was used to assess volumetric bone density (vBMD), microarchitecture, and biomechanical properties at the distal radius and the metacarpophalangeal (MCP) joint during routine follow-up. Generalised additive models, adjusted for age, sex, and body weight, were used to analyse the relationship between bone changes, diagnosis, and disease activity over time, spanning up to 7 years. RESULTS: We analysed 946 radius and 916 MCP scans from 482 patients (175 PsA, 221 RA+, and 86 RA-) over a mean ± SD follow-up period of 25 ± 27 months (maximum: 108) and 24 ± 30 months (maximum: 142), respectively. At all-time points compared, RA+ patients had lower trabecular vBMD than PsA (difference: 14.71 mg hydroxyapatite [HA]/cm³; 95% CI, 2.85-26.58; p = .003 at baseline) and RA- (difference: 16.92 mg HA/cm³; 95% CI, 0.97-32.86; p = .010 at baseline) patients. Longitudinally, total vBMD declined by -16.2 mg HA/cm³ (95% CI, -20.9 to -11.4; p < .001) in RA+ patients over 5 years, with smaller losses in RA- and PsA patients. PsA patients showed stable bone quality with cortical sparing; RA+ patients showed the most pronounced trabecular vBMD and microarchitectural loss; and RA- patients showed intermediate changes. Sustained remission preserved bone, while high disease activity was associated with deterioration. CONCLUSIONS: Longitudinal HR-pQCT shows site- and serostatus-dependent bone deterioration across inflammatory arthritides; RA+ patients have the worst trabecular changes, and those with PsA have relative cortical preservation. Sustained remission preserves bone structure and strength.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidArthritis, PsoriaticBone DensityRadiusMetacarpophalangeal JointHumansFemaleMaleMiddle AgedBiomechanical PhenomenaTomography, X-Ray ComputedDisease ProgressionAgedAdultSeverity of Illness IndexLongitudinal Studies

Autor:innen und Institutionen

  • Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany; Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-Uni…
  • Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, U…
  • Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany; Department Materials Meet Life, Swiss Federal Laboratories for…

Förderung

  • Deutsche Forschungsgemeinschaft
  • Friedrich-Alexander-Universitat Erlangen-Nurnberg
  • Innovative Medicines Initiative
  • Bundesministerium fur Bildung und Forschung Dienststelle Bonn
  • Janssen Pharmaceutica
  • European Federation of Pharmaceutical Industries & Associations
  • Horizon 2020 Framework Programme
  • European Research Council

Zitieren

APA

Temiz, A., Kemenes, S., Bayat, S., Yalcin-Mutlu, M., Schuster, L., Hast-Sribike, K., Liphardt, A. M., Simon, D., Kleyer, A., Schett, G., Fagni, F., & Tascilar, K. (2026). Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years. Annals of the Rheumatic Diseases, 85(11), 2151-2163. https://doi.org/10.1016/j.ard.2026.07.017

Vancouver

Temiz A, Kemenes S, Bayat S, Yalcin-Mutlu M, Schuster L, Hast-Sribike K, et al. Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years. Annals of the Rheumatic Diseases. 2026;85(11):2151-2163. doi:10.1016/j.ard.2026.07.017

BibTeX
@article{Temiz2026,
  author = {Temiz, Alp and Kemenes, Stephan and Bayat, Sara and Yalcin-Mutlu, Melek and Schuster, Louis and Hast-Sribike, Katharina and Liphardt, Anna-Maria and Simon, David and Kleyer, Arnd and Schett, Georg and Fagni, Filippo and Tascilar, Koray},
  title = {Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {11},
  pages = {2151--2163},
  doi = {10.1016/j.ard.2026.07.017}
}
Kostenlos starten →